61 related articles for article (PubMed ID: 10851473)
1. The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer.
Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Cencioni S; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):257-64. PubMed ID: 10851473
[TBL] [Abstract][Full Text] [Related]
2. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
[TBL] [Abstract][Full Text] [Related]
3. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
[TBL] [Abstract][Full Text] [Related]
4. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
[TBL] [Abstract][Full Text] [Related]
5. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of immunological evaluation in colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Maccarone D; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Dec; 11(6):355-61. PubMed ID: 10851496
[TBL] [Abstract][Full Text] [Related]
7. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
8. Potent control of tumor growth by CEA/CD3-bispecific single-chain antibody constructs that are not competitively inhibited by soluble CEA.
Lutterbuese R; Raum T; Kischel R; Lutterbuese P; Schlereth B; Schaller E; Mangold S; Rau D; Meier P; Kiener PA; Mulgrew K; Oberst MD; Hammond SA; Baeuerle PA; Kufer P
J Immunother; 2009 May; 32(4):341-52. PubMed ID: 19342971
[TBL] [Abstract][Full Text] [Related]
9. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
[TBL] [Abstract][Full Text] [Related]
10. Immunological directives for biotherapy improvement in the treatment of colorectal cancer.
Pellegrini P; Berghella AM; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Apr; 11(2):113-8. PubMed ID: 10851527
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer.
Pellegrini P; Contasta I; Berghella AM; Gargano E; Mammarella C; Adorno D
Cancer Immunol Immunother; 2000 Sep; 49(7):388-94. PubMed ID: 10999465
[TBL] [Abstract][Full Text] [Related]
12. The effect of colorectal cancer upon host peripheral immune cell function.
Evans CF; Galustian C; Bodman-Smith M; Dalgleish AG; Kumar D
Colorectal Dis; 2010 Jun; 12(6):561-9. PubMed ID: 19250260
[TBL] [Abstract][Full Text] [Related]
13. Native soluble carcinoembryonic antigen is not involved in the impaired activity of CD56 natural killer cells in malignant pleural effusion.
Qi J; Li D; Feng J; Yang S; Su Y; Fang M; Tan Z; Shi H; Yan X; Gong F; Zheng F
Respiration; 2013; 86(3):216-23. PubMed ID: 23258197
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma.
Polimeno M; Napolitano M; Costantini S; Portella L; Esposito A; Capone F; Guerriero E; Trotta A; Zanotta S; Pucci L; Longo N; Perdonà S; Pignata S; Castello G; Scala S
BJU Int; 2013 Sep; 112(5):686-96. PubMed ID: 23495770
[TBL] [Abstract][Full Text] [Related]
15. Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding.
Contasta I; Pellegrini P; Berghella AM; Del Beato T ; Canossi A; Maccarone D; Papola F; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Dec; 12(6):385-93. PubMed ID: 10851492
[TBL] [Abstract][Full Text] [Related]
16. [CEA, CA-19-9 and il-8, sTNFRII and sil-2R in persons at high risk of colorectal cancer].
Grotowski M; Wojtuń S
Pol Merkur Lekarski; 2003 Apr; 14(82):327-30. PubMed ID: 12868194
[TBL] [Abstract][Full Text] [Related]
17. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
18. Immunoresponsiveness of cancer patients: effect of blood transfusion and immune reactivity of tumor infiltrating lymphocytes.
Quintiliani L; Iudicone P; Di Girolamo M; Buzzonetti A; Guglielmetti M; Lapponi P; Traietti P; Monno D; Giuliani E
Cancer Detect Prev; 1995; 19(6):518-26. PubMed ID: 8925521
[TBL] [Abstract][Full Text] [Related]
19. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput assay of NK cell activity in whole blood and its clinical application.
Lee SB; Cha J; Kim IK; Yoon JC; Lee HJ; Park SW; Cho S; Youn DY; Lee H; Lee CH; Lee JM; Lee KY; Kim J
Biochem Biophys Res Commun; 2014 Mar; 445(3):584-90. PubMed ID: 24561245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
